Travoprost Five Day Posology Study

NCT01114893 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Open-angle Glaucoma (OAG)
Ocular Hypertension

Interventions

DRUG: Travoprost 0.004%
DRUG: Travoprost Vehicle
DRUG: Travoprost (Groups A, B and C)

Sponsor

Alcon Research